Mechanistically, tricin inhibited KRASG12C-mutant NSCLC cell growth primarily by suppressing the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway. Here, CD274 is linked to non-small cell lung carcinoma.